|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash ( used in ) provided by operating activities | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Inventory reserves | |||||
| Amortization of deferred financing costs | |||||
| Earnings in equity method investment | |||||
| Cash receipts from Holdings after the Spin-Off | |||||
| Loss on extinguishment of debt | |||||
| Revaluation of earnout consideration liability | |||||
| Revaluation of warrant liability | |||||
| Non-cash operating lease expense | |||||
| Change in fair value of derivative liability | |||||
| Loss on remeasurement of TRA liability | |||||
| Deferred tax (benefit) expense | |||||
| Changes in assets and liabilities | |||||
| Accounts receivable | |||||
| Inventories, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deposits and other assets | |||||
| Lease liabilities | |||||
| Other liabilities | |||||
| Net cash (used in ) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Investment in SAFE | |||||
| Resolute Holdings cash deconsoldiated as a result of the Spin-Off | |||||
| Holdings cash deconsolidated as a result of the CompoSecure Management Agreement | |||||
| Capitalized software expenditures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Business combination and PIPE financing | |||||
| Proceeds from employee stock purchase plan and exercise of options | |||||
| Proceeds from convertible notes | |||||
| Payments for taxes related to net share settlement of equity awards and earnout liability | |||||
| Payments for taxes related to net share settlement of Earnouts | |||||
| Proceeds from the exercise of warrants | |||||
| Purchase of treasury shares | |||||
| Payment of term loan | |||||
| Proceeds from term loan | |||||
| Payment of tax receivable agreement liability | |||||
| Deferred finance costs related to debt modification | |||||
| Distributions pursuant to the business combination | |||||
| Tax distributions to non-controlling members | |||||
| Special distribution to non-controlling members | |||||
| Dividend to Class A shareholders | |||||
| Issuance cost related to Business Combination | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents , beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplementary disclosure of cash flow information: | |||||
| Cash paid for interest expense | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash financing activities: | |||||
| Operating lease ROU assets exchanged for lease liabilities | |||||
| Derivative asset - interest rate swap | |||||
| Non-cash portion of warrant exercise | |||||
| Settlement of earnout | |||||
| Contribution to Holdings for stock-based compensation | |||||
| Holdings net liabilities, excluding cash and cash equivalent, deconsolidated as a result of CompoSecure Management Agreement | |||||
| Resolute Holdings net liabilities, excluding cash and cash equivalent, deconsolidated as a result of Spin-Off | |||||
Loading...